Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
107last 24h
3126last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
Investing.com2d agobullish
Hims & Hers stock climbs on direct partnership with Eli Lilly for obesity drugsInvestor's Business Daily2d agobullish
Hims & Hers Surges On 'Surprising And Inevitable' Deal With Eli LillyBarrons.com2d agoneutral
Why Hims & Hers Health Stock Was in Dire Need of This Eli Lilly AgreementBarrons.com4d agoneutral
Novo Nordisk Stock Shrugs Off Eli Lilly Threat as Weight-Loss Pill Shines in EarningsBarrons.com4d agoneutral
Pfizer CEO Bourla Bets the Viagra Playbook Can Crack the Obesity Market24/7 Wall St.5d agoneutral
Merck’s Pipeline Could Be Its Next Big Growth Driver. Its Latest Earnings Offer a Clue.24/7 Wall St.6d agobullish
Eli Lilly Jumped 6% After Earnings. It’s Up 68% in a Year. Where Does the Target Go Now?MT Newswires6d agoneutral
Berenberg Adjusts Price Target on Eli Lilly and Company to $1,570 From $1,400Motley Fool8d agobullish
After Eli Lilly’s Explosive Earnings Report, Is It Too Late to Buy the Stock?GuruFocus.com8d agoneutral
OmniAb Inc (OABI) (Q3 2026) Earnings Call Highlights: Lilly Deal, Raised Guidance and a Busy ...The Wall Street Journal39d agoneutral
The Next Frontier for Obesity Drugs Isn’t How Much Weight You Lose, but What KindThe Wall Street Journal39d agoneutral
Lilly’s Next-Gen Obesity Drug Helps People Lose Even More Weight in Study